Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy

Por Kang, Min H., Reynolds, C. Patrick
Publicado em 2009

Analysis of Fenretinide and its metabolites in human plasma by liquid chromatography-tandem mass spectrometry and its application to clinical pharmacokinetics

Por Cho, Hwang Eui, Kang, Min H
Publicado no J Pharm Biomed Anal (2016)

Modulation of glucocorticoid resistance in pediatric T-cell Acute Lymphoblastic Leukemia by increasing BIM expression with the PI3K/mTOR inhibitor BEZ235

Por Hall, Connor P., Reynolds, C. Patrick, Kang, Min H.
Publicado no Clin Cancer Res (2015)

c-Abl Is an Upstream Regulator of Acid Sphingomyelinase in Apoptosis Induced by Inhibition of Integrins αvβ3 and αvβ5

Por Ren, Xiuhai, Xu, Jingying, Cooper, Jason P., Kang, Min H., Erdreich-Epstein, Anat
Publicado em 2012

C22:0- and C24:0-dihydroceramides Confer Mixed Cytotoxicity in T-Cell Acute Lymphoblastic Leukemia Cell Lines

Por Holliday Jr., Michael W., Cox, Stephen B., Kang, Min H., Maurer, Barry J.
Publicado em 2013

Initial Testing (Stage 1) of the Topoisomerase II inhibitor Pixantrone, by the Pediatric Preclinical Testing Program

Por Kurmasheva, Raushan T., Reynolds, C. Patrick, Kang, Min H., Allievi, Cecilia, Houghton, Peter J., Smith, Malcolm A.
Publicado em 2013

Differential Virus Replication, Cytokine Production, and Antigen-Presenting Function by Microglia from Susceptible and Resistant Mice Infected with Theiler's Virus

Por Jin, Young-Hee, Mohindru, Mani, Kang, Min H., Fuller, Alyson C., Kang, Bongsu, Gallo, Daniel, Kim, Byung S.
Publicado em 2007

National Cancer Institute Pediatric Preclinical Testing Program: Model Description for In Vitro Cytotoxicity Testing

Por Kang, Min H., Smith, Malcolm A., Morton, Christopher L., Keshelava, Nino, Houghton, Peter J., Reynolds, C. Patrick
Publicado em 2010

Synergistic Activity of Rapamycin and Dexamethasone in vitro and in vivo in acute lymphoblastic leukemia via cell-cycle arrest and apoptosis

Por Zhang, Chong, Ryu, Yong-Ku, Chen, Taylor Z., Hall, Connor P., Webster, Daniel R., Kang, Min H.
Publicado em 2011

Metabolic characteristics of 13-cis-retinoic acid (isotretinoin) and anti-tumour activity of the 13-cis-retinoic acid metabolite 4-oxo-13-cis-retinoic acid in neuroblastoma

Por Sonawane, Poonam, Cho, Hwang Eui, Tagde, Ashujit, Verlekar, Dattesh, Yu, Alice L, Reynolds, C Patrick, Kang, Min H
Publicado no Br J Pharmacol (2014)

Evaluation of Arsenic Trioxide by the Pediatric Preclinical Testing Program with a Focus on Ewing Sarcoma

Por Smith, Malcolm A., Kang, Min H., Reynolds, C. Patrick, Kurmasheva, Raushan T., Alexander, Denise, Billups, Catherine A., Toretsky, Jeffrey A., Houghton, Peter J.
Publicado em 2012

Fenretinide metabolism in humans and mice: utilizing pharmacological modulation of its metabolic pathway to increase systemic exposure

Por Cooper, Jason P, Hwang, Kyunghwa, Singh, Hardeep, Wang, Dong, Reynolds, C Patrick, Curley, Robert W, Williams, Simon C, Maurer, Barry J, Kang, Min H
Publicado em 2011

Initial Testing (Stage 1) of the Anti-Microtubule Agents Cabazitaxel and Docetaxel, by the Pediatric Preclinical Testing Program

Por Reynolds, C. Patrick, Kang, Min H., Maris, John M., Kolb, E. Anders, Gorlick, Richard, Wu, Jianrong, Kurmasheva, Raushan T., Houghton, Peter J., Smith, Malcolm A.
Publicado no Pediatr Blood Cancer (2015)

Initial Testing of a Monoclonal Antibody (IMC-A12) against IGF-1R by the Pediatric Preclinical Testing Program

Por Houghton, Peter J., Morton, Christopher L., Gorlick, Richard, Kolb, E. Anders, Keir, Stephen T., Reynolds, C. Patrick, Kang, Min H., Maris, John M., Wu, Jianrong, Smith, Malcolm A.
Publicado em 2010

Initial Testing of the Replication Competent Seneca Valley Virus (NTX-010) by the Pediatric Preclinical Testing Program

Por Morton, Christopher L., Houghton, Peter J., Kolb, E. Anders, Gorlick, Richard, Reynolds, C. Patrick, Kang, Min H., Maris, John M., Keir, Stephen T., Wu, Jianrong, Smith, Malcolm A.
Publicado em 2010

Pharmacokinetic Modeling of an Induction Regimen for In Vivo Combined Testing of Novel Drugs against Pediatric Acute Lymphoblastic Leukemia Xenografts

Por Szymanska, Barbara, Wilczynska-Kalak, Urszula, Kang, Min H., Liem, Natalia L. M., Carol, Hernan, Boehm, Ingrid, Groepper, Daniel, Reynolds, C. Patrick, Stewart, Clinton F., Lock, Richard B.
Publicado em 2012

Initial Solid Tumor Testing (Stage 1) of AZD1480, an Inhibitor of Janus Kinases 1 and 2 by the Pediatric Preclinical Testing Program

Por Houghton, Peter J., Kurmasheva, Raushan T., Lyalin, Dmitry, Maris, John M., Kolb, E. Anders, Gorlick, Richard, Reynolds, C. Patrick, Kang, Min H., Keir, Stephen T., Wu, Jianrong, Smith, Malcolm A.
Publicado em 2014

Initial Testing (Stage 1) of the Polyamine Analog PG11047 by the Pediatric Preclinical Testing Program

Por Smith, Malcolm A., Maris, John M., Lock, Richard, Kolb, E. Anders, Gorlick, Richard, Keir, Stephen T., Carol, Hernan, Morton, Christopher L., Reynolds, C. Patrick, Kang, Min H., Houghton, Peter J.
Publicado em 2011

Initial Testing (Stage 1) the Pediatric Preclinical Testing Program of RO4929097, a γ-Secretase Inhibitor Targeting Notch Signaling

Por Kolb, E. Anders, Gorlick, Richard, Keir, Stephen T., Maris, John M., Lock, Richard, Carol, Hernan, Kurmasheva, Raushan T., Reynolds, C. Patrick, Kang, Min H., Wu, Jianrong, Houghton, Peter J., Smith, Malcolm A.
Publicado em 2011

Probable fatal drug interaction between intravenous fenretinide, ceftriaxone, and acetaminophen: a case report from a New Approaches to Neuroblastoma (NANT) Phase I study

Por Kang, Min H, Villablanca, Judith G, Glade Bender, Julia L, Matthay, Katherine K, Groshen, Susan, Sposto, Richard, Czarnecki, Scarlett, Ames, Matthew M, Reynolds, C Patrick, Marachelian, Araz, Maurer, Barry J
Publicado em 2014